Sunvozertinib

• CAS: 2370013-12-8
• Catalog Number: ACM2370013128
• Category: Inhibitors
• Molecular Weight: 584.09
• Molecular Formula: C29H35ClFN7O3
• Description: Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective EGFR tyrosine kinase inhibitor. Sunvozertinib shows activity against EGFRexon20ins and other mutations. In both cell lines and xenograft models, sunvozertinib shows potent antitumor activity. In the two ongoing phase I clinical studies, sunvozertinib was tolerated up to 400 mg once daily.
• Synonyms: Sunvozertinib; DZD 9008; (DZD-9008; DZD9008
• IUPAC Name: N-{5-({4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl}amino)-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide
• Canonical SMILES: C=CC(NC1=CC(NC2=NC=CC(NC3=CC(Cl)=C(F)C=C3C(C)(O)C)=N2)=C(OC)C=C1N4C[C@H](N(C)C)CC4)=O
• InChI: InChI=1S/C29H35ClFN7O3/c1-7-27(39)34-22-14-23(25(41-6)15-24(22)38-11-9-17(16-38)37(4)5)35-28-32-10-8-26(36-28)33-21-13-19(30)20(31)12-18(21)29(2,3)40/h7-8,10,12-15,17,40H,1,9,11,16H2,2-6H3,(H,34,39)(H2,32,33,35,36)/t17-/m1/s1
• InChI Key: BTMKEDDEMKKSEF-QGZVFWFLSA-N
• Solubility: To be determined
• Appearance: Solid powder
• Shelf Life: >2 years if stored properly
• Storage: Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
• Drug Formulation: To be determined
• Elemental Analysis: C, 59.63; H, 6.04; Cl, 6.07; F, 3.25; N, 16.79; O, 8.22
• Exact Mass: 583.2474
• HS Tariff Code: 2934.99.9001
• Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
• Stock Solution Storage: 0-4 °C for short term (days to weeks), or -20 °C for long term (months).